v3.26.1
Share-Based Payment Transactions (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Payment Transactions [Abstract]  
Schedule of Expenses Due to Share-Based Compensation

The expenses due to share-based compensation for the years ended December 31, 2025, 2024 and 2023, recognized in the consolidated financial statements in respect of the share option plan of the Company are shown in the following table, detailed by expense classification:

 

   Year ended December 31, 
   2025   2024   2023 
Research and development expenses  $85   $45   $34 
General and administrative expenses   1,103    524    162 
                
   $1,188   $569   $196 
Schedule of Weighted Average Exercise Prices of Share Options The following table lists the number of Share Options, the weighted average exercise prices of Share Options and changes in directors (and former directors), officers, employees and consultants Share Options during the years ended on December 31, 2025, and 2024:
   Number of
Share
Options
   Weighted
average
exercise
price
 
       USD 
2025:        
Share Options outstanding at the beginning of the year   36    53,940.24 
           
Share Options outstanding at the end of the year   36    53,940.24 
           
Share Options exercisable at the end of the year   36    53,940.24 
           
2024:          
Share Options outstanding at the beginning of the year   37    31,426.92 
           
Share Options outstanding at the end of the year   36    53,940.24 
           
Share Options exercisable at the end of the year   36    53,940.24 
Schedule of RSU transaction

RSU transactions for the years ended December 31, 2025, and 2024 are as follows:

 

   Number 
Balance, January 1, 2024   
-
 
RSUs granted   5,628 

Vesting of RSUs

   
-
 
Balance, December 31, 2024   5,628 
      

Vesting of RSUs

   (4,205)
RSUs granted   56,111 
Balance, December 31, 2025   57,534